France · Delayed Price · Currency is EUR Vetoquinol Statistics
Total Valuation
Vetoquinol has a market cap or net worth of EUR 781.00 million. The enterprise value is 575.29 million.
| Market Cap | 781.00M |
| Enterprise Value | 575.29M |
Important Dates
The next confirmed earnings date is Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
Vetoquinol has 11.62 million shares outstanding. The number of shares has decreased by -1.47% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | -1.47% |
| Shares Change (QoQ) | -2.51% |
| Owned by Insiders (%) | 4.08% |
| Owned by Institutions (%) | 8.53% |
| Float | 3.65M |
Valuation Ratios
The trailing PE ratio is 13.62 and the forward PE ratio is 13.54.
| PE Ratio | 13.62 |
| Forward PE | 13.54 |
| PS Ratio | 1.49 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 2.00 |
| P/FCF Ratio | 14.19 |
| P/OCF Ratio | 10.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.25, with an EV/FCF ratio of 10.45.
| EV / Earnings | 10.03 |
| EV / Sales | 1.09 |
| EV / EBITDA | 5.25 |
| EV / EBIT | 7.21 |
| EV / FCF | 10.45 |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.08 |
| Quick Ratio | 2.21 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.28 |
| Interest Coverage | 63.61 |
Financial Efficiency
Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 14.79%.
| Return on Equity (ROE) | 9.82% |
| Return on Assets (ROA) | 6.62% |
| Return on Invested Capital (ROIC) | 14.79% |
| Return on Capital Employed (ROCE) | 12.98% |
| Weighted Average Cost of Capital (WACC) | 9.11% |
| Revenue Per Employee | 214,216 |
| Profits Per Employee | 23,374 |
| Employee Count | 2,486 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, Vetoquinol has paid 22.94 million in taxes.
| Income Tax | 22.94M |
| Effective Tax Rate | 28.57% |
Stock Price Statistics
The stock price has decreased by -9.56% in the last 52 weeks. The beta is 0.90, so Vetoquinol's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -9.56% |
| 50-Day Moving Average | 76.20 |
| 200-Day Moving Average | 78.40 |
| Relative Strength Index (RSI) | 26.40 |
| Average Volume (20 Days) | 3,784 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vetoquinol had revenue of EUR 525.69 million and earned 57.36 million in profits. Earnings per share was 4.94.
| Revenue | 525.69M |
| Gross Profit | 307.96M |
| Operating Income | 79.83M |
| Pretax Income | 80.28M |
| Net Income | 57.36M |
| EBITDA | 103.44M |
| EBIT | 79.83M |
| Earnings Per Share (EPS) | 4.94 |
Balance Sheet
The company has 221.08 million in cash and 15.29 million in debt, with a net cash position of 205.78 million or 17.71 per share.
| Cash & Cash Equivalents | 221.08M |
| Total Debt | 15.29M |
| Net Cash | 205.78M |
| Net Cash Per Share | 17.71 |
| Equity (Book Value) | 591.44M |
| Book Value Per Share | 50.88 |
| Working Capital | 309.31M |
Cash Flow
In the last 12 months, operating cash flow was 72.08 million and capital expenditures -17.02 million, giving a free cash flow of 55.05 million.
| Operating Cash Flow | 72.08M |
| Capital Expenditures | -17.02M |
| Depreciation & Amortization | 23.61M |
| Net Borrowing | 1.05M |
| Free Cash Flow | 55.05M |
| FCF Per Share | 4.74 |
Margins
Gross margin is 58.58%, with operating and profit margins of 15.19% and 10.91%.
| Gross Margin | 58.58% |
| Operating Margin | 15.19% |
| Pretax Margin | 15.27% |
| Profit Margin | 10.91% |
| EBITDA Margin | 19.68% |
| EBIT Margin | 15.19% |
| FCF Margin | 10.47% |
Dividends & Yields
This stock pays an annual dividend of 0.93, which amounts to a dividend yield of 1.35%.
| Dividend Per Share | 0.93 |
| Dividend Yield | 1.35% |
| Dividend Growth (YoY) | 4.49% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 18.13% |
| Buyback Yield | 1.47% |
| Shareholder Yield | 2.79% |
| Earnings Yield | 7.34% |
| FCF Yield | 7.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vetoquinol has an Altman Z-Score of 4.7 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.7 |
| Piotroski F-Score | 6 |